Hain Celestial Group Inc., the Lake Success-based organic and natural products maker that disclosed last week it is under investigation by the Securities and Exchange Commission, has agreed to acquire United Kingdom soup maker Yorkshire Provender Ltd.
The transaction, announced Thursday, is subject to clearance from the Competition and Markets Authority in the United Kingdom. Terms of the deal were not disclosed.
Yorkshire Provender’s gluten-free soups are sold by several retailers, on-the-go food outlets and food-service providers in the United Kingdom. The company, founded in 2007 and based in North Yorkshire, England, had about $7.5 million in net sales last year and is expected to add to Hain Celestial’s earnings in fiscal year 2018.
“We are excited to work together with the Yorkshire Provender team and leverage our combined infrastructures to drive future growth,” James Skidmore, chief executive of the Hain Daniels Group, a subsidiary of Hain Celestial, said in a statement.
Yorkshire Provender will continue to operate from its North Yorkshire location.
Last Friday, Hain Celestial disclosed in a regulatory filing it is being investigated by the SEC for its accounting practices. The company said it is cooperating with the investigation.
Hain notified the SEC in August that it was delaying the release of its financial results for its fourth quarter and fiscal 2016, ended June 30.
In November the company said an independent review found “no evidence of intentional wrongdoing” in connection with its financial reporting. Hain, whose brands include Celestial Seasonings tea, Earth’s Best baby food, Terra chips and Spectrum oils, had been recognizing revenue when products were shipped to certain distributors rather than when the products were sold to customers.
Hain shares closed down 50 cents to $34.46 on the Nasdaq Stock Market Thursday. Its shares are down 37 percent since the company’s financial reporting news on Aug. 15.
By Aisha Al-Muslim
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.